Bevacizumab, a humanized anti‐angiogenic monoclonal antibody for the treatment of colorectal cancer
I Krämer, HP Lipp - Journal of clinical pharmacy and …, 2007 - Wiley Online Library
Angiogenesis is the process by which new blood vessels are created from pre‐existing
vessels. It is essential for the growth and development of normal cells and tissues during …
vessels. It is essential for the growth and development of normal cells and tissues during …
Bevacizumab, a humanized anti-angiogenic monoclonal antibody for the treatment of colorectal cancer.
I Krämer, HP Lipp - Journal of Clinical Pharmacy & …, 2007 - search.ebscohost.com
Angiogenesis is the process by which new blood vessels are created from pre-existing
vessels. It is essential for the growth and development of normal cells and tissues during …
vessels. It is essential for the growth and development of normal cells and tissues during …
Bevacizumab, a humanized anti-angiogenic monoclonal antibody for the treatment of colorectal cancer
I Krämer, HP Lipp - Journal of clinical pharmacy and …, 2007 - pubmed.ncbi.nlm.nih.gov
Angiogenesis is the process by which new blood vessels are created from pre-existing
vessels. It is essential for the growth and development of normal cells and tissues during …
vessels. It is essential for the growth and development of normal cells and tissues during …
[引用][C] Bevacizumab, a humanized anti-angiogenic monoclonal antibody for the treatment of colorectal cancer
I KRÄMER, HP LIPP - Journal of clinical pharmacy and …, 2007 - pascal-francis.inist.fr
Bevacizumab, a humanized anti-angiogenic monoclonal antibody for the treatment of
colorectal cancer CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
colorectal cancer CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …